Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

Influence of cachexia on chemotherapy toxicity

Dr Michael Sawyer – University of Alberta, Canada

Influence of cachexia on chemotherapy toxicity ( Dr Michael Sawyer – University of Alberta, Canada )

Advances in the treatment of colorectal cancer

Dr Patrick Johnston - Queens University, Belfast, UK

Advances in the treatment of colorectal cancer ( Dr Patrick Johnston - Queens University, Belfast, UK )

New genetic sub-types of breast, ovarian and prostate cancer

Dr Paul Pharoah – University of Cambridge, UK

New genetic sub-types of breast, ovarian and prostate cancer ( Dr Paul Pharoah – University of Cambridge, UK )

Participation in clinical trials

Richard Stephens – VNCRI and NCRN Consumer Liaison Groups

Participation in clinical trials ( Richard Stephens – VNCRI and NCRN Consumer Liaison Groups )

Patient involvement in improvements in standard of care

Tom Haswell - VNCRI and NCRN Consumer Liaison Groups

Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )

Benefits of participating in clinical trials and patient liaison groups

Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups

Benefits of participating in clinical trials and patient liaison groups ( Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups )

Treatment of antiphospholipid syndrome with aspirin

Prof Graham Hughes – St Thomas Hospital, London, UK

Treatment of antiphospholipid syndrome with aspirin ( Prof Graham Hughes – St Thomas Hospital, London, UK )

The Helico Eradication Aspirin Trial (HEAT)

Prof Chris Hawkey – The University of Nottingham, UK

The Helico Eradication Aspirin Trial (HEAT) ( Prof Chris Hawkey – The University of Nottingham, UK )

Highlights of the 2012 Aspirin Foundation meeting

Nick Henderson – Executive Director, Aspirin Foundation

Highlights of the 2012 Aspirin Foundation meeting ( Nick Henderson – Executive Director, Aspirin Foundation )

Effects of aspirin on the progression of cancer

Prof Peter Rothwell – Oxford University, UK

Effects of aspirin on the progression of cancer ( Prof Peter Rothwell – Oxford University, UK )

Recent evidence to support the use of aspirin in the treatment of cancer

Dr Ruth Langley – Medical Research Council, London, UK

Recent evidence to support the use of aspirin in the treatment of cancer ( Dr Ruth Langley – Medical Research Council, London, UK )

Effectiveness of PARP inhibitors in ovarian cancer

Prof Jonathan Ledermann - University College London, UK

Effectiveness of PARP inhibitors in ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )

More from ecancer